Cargando…
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
IMPORTANCE: Acne is a common, multifactorial skin condition, and treatments with novel mechanisms have been elusive. OBJECTIVE: To assess the safety and efficacy of clascoterone cream, 1%, a novel topical androgen receptor inhibitor, in 2 phase 3 randomized clinical trials (CB-03-01/25 and CB-03-01/...
Autores principales: | Hebert, Adelaide, Thiboutot, Diane, Stein Gold, Linda, Cartwright, Martina, Gerloni, Mara, Fragasso, Enrico, Mazzetti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177662/ https://www.ncbi.nlm.nih.gov/pubmed/32320027 http://dx.doi.org/10.1001/jamadermatol.2020.0465 |
Ejemplares similares
-
Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
por: Sanchez, Carol, et al.
Publicado: (2022) -
Use of topical clascoterone for the treatment of hidradenitis suppurativa
por: Cunningham, Kaitlynne N., et al.
Publicado: (2023) -
Why Topical Retinoids Are Mainstay of Therapy for Acne
por: Leyden, James, et al.
Publicado: (2017) -
Efficacy and Safety of Topical Nitric Oxide−Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial
por: Browning, John C., et al.
Publicado: (2022) -
Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel
por: Tan, Jerry, et al.
Publicado: (2021)